Partanen J - Search Results

1

Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects.

Vauhkonen I, Niskanen L, Ryynänen M, Voutilainen R, Partanen J, Töyry J, Mercuri M, Rauramaa R, Uusitupa M. Vauhkonen I, et al. Among authors: partanen j. Diabet Med. 1997 Sep;14(9):748-56. doi: 10.1002/(SICI)1096-9136(199709)14:9<748::AID-DIA469>3.0.CO;2-N. Diabet Med. 1997. PMID: 9300224

2

Novel human FGF receptors with distinct expression patterns.

Korhonen J, Partanen J, Eerola E, Vainikka S, Ilvesmäki V, Voutilainen R, Julkunen M, Mäkelä T, Alitalo K. Korhonen J, et al. Among authors: partanen j. Ann N Y Acad Sci. 1991;638:403-5. doi: 10.1111/j.1749-6632.1991.tb49053.x. Ann N Y Acad Sci. 1991. PMID: 1664691 No abstract available.

3

Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus.

Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Partanen J, et al. N Engl J Med. 1995 Jul 13;333(2):89-94. doi: 10.1056/NEJM199507133330203. N Engl J Med. 1995. PMID: 7777034 Free article.

4

Short-term and long-term memory in elderly patients with NIDDM.

Helkala EL, Niskanen L, Viinamaki H, Partanen J, Uusitupa M. Helkala EL, et al. Among authors: partanen j. Diabetes Care. 1995 May;18(5):681-5. doi: 10.2337/diacare.18.5.681. Diabetes Care. 1995. PMID: 8586007

5

Spectral analysis of EEG in Alzheimer's disease: relation to apolipoprotein E polymorphism.

Lehtovirta M, Partanen J, Könönen M, Soininen H, Helisalmi S, Mannermaa A, Ryynänen M, Hartikainen P, Riekkinen P Sr. Lehtovirta M, et al. Among authors: partanen j. Neurobiol Aging. 1996 Jul-Aug;17(4):523-6. doi: 10.1016/0197-4580(96)00024-3. Neurobiol Aging. 1996. PMID: 8832625

6

ERPs reveal deficits in automatic cerebral stimulus processing in patients with NIDDM.

Vanhanen M, Karhu J, Koivisto K, Pääkkönen A, Partanen J, Laakso M, Riekkinen P Sr. Vanhanen M, et al. Among authors: partanen j. Neuroreport. 1996 Nov 4;7(15-17):2767-71. doi: 10.1097/00001756-199611040-00072. Neuroreport. 1996. PMID: 8981464

7

Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population.

Jääskeläinen J, Levo A, Voutilainen R, Partanen J. Jääskeläinen J, et al. Among authors: partanen j. J Clin Endocrinol Metab. 1997 Oct;82(10):3293-7. doi: 10.1210/jcem.82.10.4271. J Clin Endocrinol Metab. 1997. PMID: 9329356

8

Tracing past population migrations: genealogy of steroid 21-hydroxylase (CYP21) gene mutations in Finland.

Levo A, Jääskeläinen J, Sistonen P, Sirén MK, Voutilainen R, Partanen J. Levo A, et al. Among authors: partanen j. Eur J Hum Genet. 1999 Feb-Mar;7(2):188-96. doi: 10.1038/sj.ejhg.5200262. Eur J Hum Genet. 1999. PMID: 10196702

9

[Prenatal dexamethasone treatment of 21-hydroxylase deficiency].

Jääskeläinen J, Partanen J, Hippeläinen M, Levo A, Voutilainen R. Jääskeläinen J, et al. Among authors: partanen j. Duodecim. 1996;112(14):1258-63. Duodecim. 1996. PMID: 10596095 Review. Finnish. No abstract available.

10

A longitudinal quantitative EEG study of Alzheimer's disease: relation to apolipoprotein E polymorphism.

Lehtovirta M, Partanen J, Könönen M, Hiltunen J, Helisalmi S, Hartikainen P, Riekkinen P Sr, Soininen H. Lehtovirta M, et al. Among authors: partanen j. Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):29-35. doi: 10.1159/000017210. Dement Geriatr Cogn Disord. 2000. PMID: 10629359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

687 results

Search Page

Filters